Martin Huber
Corporate Officer/Principal bij NAUTILUS BIOTECHNOLOGY, INC.
Profiel
Martin Huber is the founder of Quantapore, Inc. which was founded in 2009.
He held the title of Chief Executive Officer & Director.
Currently, he is the VP-Biochemistry & Flow Cell Development at Nautilus Biotechnology, Inc. where he started in 2023.
Dr. Huber has a graduate and doctorate degree from the University of Vienna.
Actieve functies van Martin Huber
| Bedrijven | Functie | Begin |
|---|---|---|
| NAUTILUS BIOTECHNOLOGY, INC. | Corporate Officer/Principal | 01-11-2023 |
Eerdere bekende functies van Martin Huber
| Bedrijven | Functie | Einde |
|---|---|---|
Quantapore, Inc.
 Quantapore, Inc. BiotechnologyHealth Technology Quantapore, Inc. develops nanopore based nucleic acid sequencing technology products. The firm's proprietary DNA sequencing technology is based on an optically labeled nanopore which interacts via energy transfer with a labeled nucleic acid sample. The company was founded by Martin Huber and Sascha C. Dennstedt in 2009 and is headquartered in Menlo Park, CA. | Founder | - |
Opleiding van Martin Huber
| University of Vienna | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| NAUTILUS BIOTECHNOLOGY, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Quantapore, Inc.
Quantapore, Inc. BiotechnologyHealth Technology Quantapore, Inc. develops nanopore based nucleic acid sequencing technology products. The firm's proprietary DNA sequencing technology is based on an optically labeled nanopore which interacts via energy transfer with a labeled nucleic acid sample. The company was founded by Martin Huber and Sascha C. Dennstedt in 2009 and is headquartered in Menlo Park, CA. | Health Technology |
